W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

Vision tools, rehabilitation, and lifestyle changes can all help improve the experience of living with diabetic macular edema (DME). Macular edema is a condition that involves swelling in the eye that ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Diabetes can lead to eye problems, and a common one is diabetic macular edema (DME), causing vision loss. A study published in Nature Medicine suggests a new experimental drug could someday help make ...

Resistant diabetic macular edema may necessitate transitioning from one intravitreal pharmacotherapy to another when the edema is persistent — a practice sometimes undertaken in clinical management.

Faricimab is as effective as aflibercept in improving visual acuity for patients with diabetic macular edema who have baseline vision of 20/50 or worse. Faricimab also provides superior reductions in ...

A recent study published in the journal Nature Medicine showed that targeting senescent cells in the retina can be a lasting disease-modifying treatment for diabetic macular edema (DME). The retina is ...

Damon Wayans raises awareness about diabetic macular edema, a hidden diabetes risk that can cause vision loss, and urges people to get regular eye exams Damon Wayans is raising awareness of diabetic ...

For patients with diabetic macular edema (DME), intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection followed by a dexamethasone (DEX) intravitreal implant demonstrates ...

Comedy icon Damon Wayans was diagnosed with Type 2 diabetes in 2008. Now, he is teaming up with Genentech and diaTribe as he serves as the spokesperson for "All Eyes on DME," a campaign designed to ...

Please provide your email address to receive an email when new articles are posted on . Two trials did not meet the primary endpoint of mean change in best corrected visual acuity from baseline to ...